Cover Image
市場調查報告書

眼炎:全球臨床實驗趨勢

Ocular Inflammation Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 338377
出版日期 內容資訊 英文 98 Pages
訂單完成後即時交付
價格
Back to Top
眼炎:全球臨床實驗趨勢 Ocular Inflammation Global Clinical Trials Review, H2, 2015
出版日期: 2015年07月24日 內容資訊: 英文 98 Pages
簡介

本報告提供眼炎臨床實驗最新趨勢相關分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,實驗對象採用狀況,彙整有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 眼炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:眼科疾病治療藥臨床實驗上眼炎的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:眼科疾病治療藥臨床實驗上眼炎的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

眼炎治療藥臨床實驗的主要參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • Valeant Pharmaceuticals International, Inc.
    • XOMA Corporation
    • Alcon, Inc.
    • F. Hoffmann-La Roche Ltd.
    • AbbVie Inc.
    • Sirion Therapeutics, Inc. (Inactive)
    • Allergan Plc
    • SIFI S.p.A
    • Celgene Corporation
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Eye Institute
    • Oregon Health & Science University
    • Medical University of Vienna
    • Moorfields Eye Hospital NHS Foundation Trust
    • The Johns Hopkins University
    • University of California, San Francisco
    • Capital Medical University
    • Duke University
    • Erasmus MC
    • Isfahan University of Medical Sciences

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2791CTIDB

GlobalData's clinical trial report, "Ocular Inflammation Global Clinical Trials Review, H2, 2015" provides an overview of Ocular Inflammation clinical trials scenario. This report provides top line data relating to the clinical trials on Ocular Inflammation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Ocular Inflammation
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Ocular Inflammation to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Ocular Inflammation to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Ocular Inflammation
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Ocular Inflammation Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Ocular Inflammation
      • Apr 20, 2015: Icon Bioscience Announces Pivotal Phase 3 Clinical Data Demonstrates Exceptional Efficacy of IBI-10090 in Reducing Inflammation Associated with Cataract Surgery
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Valeant Pharmaceuticals International, Inc.
      • Clinical Trial Overview of Valeant Pharmaceuticals International, Inc.
      • XOMA Corporation
      • Clinical Trial Overview of XOMA Corporation
      • Alcon, Inc.
      • Clinical Trial Overview of Alcon, Inc.
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
      • Sirion Therapeutics, Inc. (Inactive)
      • Clinical Trial Overview of Sirion Therapeutics, Inc. (Inactive)
      • Allergan Plc
      • Clinical Trial Overview of Allergan Plc
      • SIFI S.p.A
      • Clinical Trial Overview of SIFI S.p.A
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • Oregon Health & Science University
      • Clinical Trial Overview of Oregon Health & Science University
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Moorfields Eye Hospital NHS Foundation Trust
      • Clinical Trial Overview of Moorfields Eye Hospital NHS Foundation Trust
      • The Johns Hopkins University
      • Clinical Trial Overview of The Johns Hopkins University
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • Capital Medical University
      • Clinical Trial Overview of Capital Medical University
      • Duke University
      • Clinical Trial Overview of Duke University
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • Isfahan University of Medical Sciences
      • Clinical Trial Overview of Isfahan University of Medical Sciences
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Region, 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Ocular Inflammation to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Ocular Inflammation Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Ocular Inflammation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Ocular Inflammation to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Ocular Inflammation Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Ocular Inflammation Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Ocular Inflammation Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Ocular Inflammation Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Ocular Inflammation Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Ocular Inflammation Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by XOMA Corporation, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Alcon, Inc., 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Sirion Therapeutics, Inc. (Inactive), 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by SIFI S.p.A, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Moorfields Eye Hospital NHS Foundation Trust, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins University, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital Medical University, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015*

List of Figures

  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Ocular Inflammation to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Ocular Inflammation Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Ocular Inflammation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Ocular Inflammation to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Ocular Inflammation Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Ocular Inflammation Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Ocular Inflammation Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Ocular Inflammation Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Ocular Inflammation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top